title: Financing gene therapy beyond phase II.
abstract: If all the gene therapy protocols now in development reach the market, not only will it be a miracle, it will also cost an estimated $37.5 billion. There are around 250 protocols currently in development, most of which are in their earliest phases. Each of them could cost between $100 million and $200 million to take to market. The money raised by gene therapy companies over the 18 months up to June 1996--550 million--would fund the development of only a small handful of protocols. Where, then, will companies get the money for clinical development?
authors.forename: A
authors.initials: A
authors.lastname: Michael
mesh_terms: D001709:Biotechnology / Q000191:economics; D002985:Clinical Protocols; D017322:Clinical Trials, Phase II as Topic / Q000191:economics*; D017326:Clinical Trials, Phase III as Topic / Q000191:economics*; D005381:Financing, Organized; D015316:Genetic Therapy / Q000191:economics*; D007449:Investments; D012109:Research Support as Topic